Your browser is no longer supported. Please, upgrade your browser.
Settings
ARRY Array BioPharma Inc. daily Stock Chart
ARRY [NASD]
Array BioPharma Inc.
Index- P/E- EPS (ttm)-0.15 Insider Own0.20% Shs Outstand141.87M Perf Week-8.73%
Market Cap1.02B Forward P/E- EPS next Y-0.57 Insider Trans-31.68% Shs Float139.97M Perf Month-6.85%
Income-6.10M PEG- EPS next Q-0.16 Inst Own86.10% Short Float20.06% Perf Quarter-2.17%
Sales45.60M P/S22.43 EPS this Y-21.10% Inst Trans17.62% Short Ratio16.69 Perf Half Y49.28%
Book/sh0.36 P/B20.03 EPS next Y-5600.00% ROA-3.80% Target Price10.14 Perf Year58.11%
Cash/sh1.34 P/C5.38 EPS next 5Y10.00% ROE90.40% 52W Range2.98 - 8.59 Perf YTD52.43%
Dividend- P/FCF- EPS past 5Y23.70% ROI-96.60% 52W High-16.07% Beta1.74
Dividend %- Quick Ratio4.40 Sales past 5Y11.00% Gross Margin-7.20% 52W Low141.95% ATR0.26
Employees198 Current Ratio4.40 Sales Q/Q-15.40% Oper. Margin-5.50% RSI (14)46.10 Volatility3.67% 3.40%
OptionableYes Debt/Eq2.15 EPS Q/Q275.00% Profit Margin-13.40% Rel Volume1.10 Prev Close7.06
ShortableYes LT Debt/Eq2.15 EarningsMay 04 BMO Payout- Avg Volume1.68M Price7.21
Recom1.60 SMA20-4.81% SMA50-2.00% SMA20020.79% Volume1,855,987 Change2.12%
Jan-26-15Reiterated Stifel Buy $6 → $9
Aug-09-13Reiterated Stifel Buy $7 → $8
Jul-23-10Upgrade UBS Neutral → Buy $4.25
Apr-22-10Downgrade UBS Buy → Neutral
Nov-05-09Upgrade UBS Neutral → Buy
Sep-08-09Downgrade UBS Buy → Neutral
Sep-04-09Downgrade Robert W. Baird Outperform → Neutral $10 → $3
Sep-04-09Downgrade Leerink Swann Outperform → Mkt Perform $6 → $2
Sep-04-09Downgrade Boenning & Scattergood Outperform → Neutral
Jun-17-09Initiated Boenning & Scattergood Outperform $6
May-07-08Reiterated Rodman & Renshaw Mkt Outperform $18 → $15
Feb-07-08Initiated William Blair Outperform
Dec-20-07Reiterated Collins Stewart Buy $17 → $16
Dec-04-07Initiated Morgan Joseph Buy $16
Nov-07-07Reiterated Collins Stewart Buy $20 → $17
Oct-09-07Initiated Lehman Brothers Overweight $16
Aug-13-07Initiated Rodman & Renshaw Mkt Outperform $18
May-23-07Initiated JP Morgan Overweight
Jan-04-07Reiterated Piper Jaffray Outperform $14 → $20
Jun-10-15 03:04PM  One Of Mark Lamperts Small-Cap Biotech Picks Has Returned 84% This Year And Its Not Done Yet at Insider Monkey
Jun-04-15 09:40AM  Redmile Group returns an estimated 9.3% in May
Jun-02-15 08:01AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement
Jun-01-15 03:30PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:00AM  Binimetinib And Encorafenib Combination Shows Promising Clinical Activity And Potential Differentiated Safety In BRAF-Mutant Melanoma PR Newswire
05:47AM  Put sale sees Array holding gains
May-28-15 09:00AM  Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting PR Newswire
May-26-15 09:00AM  Array BioPharma To Present At The Jefferies 2015 Global Healthcare Conference PR Newswire
May-15-15 01:04PM  ARRAY BIOPHARMA INC Financials
May-10-15 08:11PM  10-Q for Array BioPharma, Inc. at Company Spotlight
May-09-15 09:45AM  4 Speculative Biotechs With Huge Analyst Targets at 24/7 Wall St.
May-07-15 09:00AM  Array BioPharma To Present At The Bank Of America Merrill Lynch Healthcare Conference And The UBS Global Healthcare Conference PR Newswire
06:09AM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report
May-06-15 02:20PM  Is Isis just what the doctor ordered? +8.07%
May-05-15 09:25AM  Array BioPharma (ARRY) Looks Good: Stock Rises 13.1% - Tale of the Tape -8.11%
May-04-15 03:59PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib +13.13%
11:00AM  What Is Really Driving Array Higher at 24/7 Wall St.
10:58AM  Array Biopharma (ARRY) Stock Jumping After Earnings Beat at TheStreet
09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today
07:18AM  Array BioPharma beats Street 3Q forecasts
07:07AM  Q3 2015 Array Biopharma Inc Earnings Release - Before Market Open
07:00AM  Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 PR Newswire
Apr-27-15 05:31PM  Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2015 On May 4, 2015 PR Newswire -6.40%
Apr-21-15 02:39PM  Biotech Investors: May 29th Could Be A Big Day
Mar-31-15 04:27PM  Array BioPharma CEO Sees Big Opportunities in the Future at TheStreet
01:50PM  Array BioPharma CEO: Novartis Deal a Massive Momentum Builder at TheStreet
Mar-30-15 05:08PM  The latest drugs being tested to fight melanoma
Mar-03-15 08:25AM  4 Biotechs Expected to See Huge Buying on PowerShares Rebalance at 24/7 Wall St.
Mar-02-15 08:10AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definit
08:00AM  Array Announces Completion Of Binimetinib And Encorafenib Transactions PR Newswire
Feb-26-15 11:02AM  Array BioPharma draws bullish bet
Feb-25-15 09:00AM  Array BioPharma To Present At The Cowen and Company Annual Healthcare Conference PR Newswire
Feb-18-15 02:26PM  How To Approach Momentum Trading Like A Pro at Investopedia
Feb-13-15 05:03PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement
Feb-10-15 03:59PM  Oncolytics Seeks Orphan Drug Status for Reolysin in the U.S. - Analyst Blog
Feb-07-15 07:07PM  10-Q for Array BioPharma, Inc. at Company Spotlight
Feb-05-15 12:30PM  Array BioPharma To Present At The Leerink Swann Global Healthcare Conference PR Newswire
Feb-04-15 05:31PM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Feb-03-15 03:08PM  CFO Moves: Visa, Array BioPharma, Epizyme at The Wall Street Journal
09:28AM  Array BioPharma reports 2Q loss AP
09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today CCBN
08:05AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Princip EDGAR Online
08:00AM  Array Biopharma Reports Financial Results For The Second Quarter Of Fiscal 2015 PR Newswire
07:07AM  Q2 2015 Array Biopharma Inc Earnings Release - Before Market Open CCBN
Jan-27-15 08:51AM  Array BioPharma (ARRY) Jumps: Stock Adds 9.8% in Session - Tale of the Tape Zacks
Jan-26-15 03:00PM  Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2015 On February 3, 2015 PR Newswire +9.85%
Jan-23-15 06:00PM  Array BioPharma shares jump on news of Novartis cancer-drug deal at American City Business Journals +40.79%
04:35PM  Equities end the day mixed... Yahoo Finance Contributors
12:02PM  Array shares jump after drugmaker details Novartis deal AP
11:52AM  Why Shares Of Array Biopharma Are Surging More Than 35% Benzinga
08:16AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
08:00AM  Array Announces Agreement To Acquire ENCORAFENIB (LGX818) PR Newswire
Jan-21-15 08:42AM  Why You Shouldn't Bet Against Array BioPharma (ARRY) Stock - Tale of the Tape Zacks
Jan-08-15 02:00PM  Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-31-14 08:59AM  19 Lesser-Known Biotech Stocks With Robust Drug Pipelines Benzinga
Dec-12-14 05:15PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definit EDGAR Online
Dec-11-14 08:15AM  The Zacks Analyst Blog Highlights: Cubist Pharmaceuticals, bluebird bio, Amgen, Incyte and Array Zacks
Dec-05-14 08:44AM  Array BioPharma (ARRY) Shares March Higher, Can It Continue? Zacks +10.29%
07:03AM  Array BioPharma, Inc. (ARRY) in Focus: Stock Soars 14.3% Zacks
Dec-04-14 02:00PM  Array BioPharma Regains Binimetinib Rights from Novartis Zacks +14.32%
12:39PM  Mid-Day Market Update: Hawaiian Electric Climbs On Merger News; Barnes & Noble Shares Slide Benzinga
10:35AM  Array BioPharma: When Losing a Partnership Is Good News at 24/7 Wall St.
10:34AM  Story Stocks from Briefing.com Briefing.com
Dec-03-14 04:06PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definit EDGAR Online
04:01PM  Array To Regain Worldwide Rights To Binimetinib PR Newswire
04:01PM  Array Biopharma Regains Rights to Cancer Drug From Novartis at TheStreet
Nov-25-14 02:00PM  Array BioPharma To Present At The Piper Jaffray And Oppenheimer 2014 Healthcare Conferences PR Newswire
Nov-24-14 10:00AM  Array BioPharma (ARRY) Is Today's Strong On High Volume Stock at TheStreet
Nov-10-14 10:00AM  Array BioPharma To Present At The Stifel 2014 Healthcare And Jefferies 2014 Global Healthcare Conferences PR Newswire
Nov-07-14 07:08PM  10-Q for Array BioPharma, Inc. Company Spotlight
Nov-05-14 04:18PM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-04-14 04:49PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Submission of Matters to a Vote o EDGAR Online
09:09AM  Array BioPharma meets 1Q profit forecasts AP
09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today CCBN
08:00AM  Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2015 PR Newswire
07:07AM  Q1 2015 Array Biopharma Inc Earnings Release - Before Market Open CCBN
Oct-29-14 01:30PM  Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2015 On November 4, 2014 PR Newswire
Oct-28-14 08:28AM  Zacks Rank #1 Additions for Tuesday Zacks +7.56%
Sep-29-14 08:05AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:00AM  Phase 2 Trial Of Binimetinib In NRAS Melanoma Shows Promising Clinical Activity PR Newswire
Sep-12-14 06:00AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in Directors or Princi EDGAR Online
Sep-11-14 06:12PM  Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical Officer PR Newswire
Sep-03-14 04:13PM  Array BioPharma To Present At The Morgan Stanley 2014 Global Healthcare Conference PR Newswire
Aug-25-14 02:18PM  Five Billionaire-Owned Biotech Stocks You Could Acquire for 100% at TheStreet +6.42%
Aug-20-14 04:59PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
Aug-15-14 08:40AM  Array BioPharma Falls Despite Narrower-than-Expected Q4 Loss Zacks
06:00AM  ARRAY BIOPHARMA INC Files SEC form 10-K, Annual Report EDGAR Online
Aug-12-14 09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today CCBN -5.12%
07:08AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
07:07AM  Q4 2014 Array BioPharma Inc. Earnings Release - Before Market Open CCBN
07:00AM  Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 PR Newswire
Jul-28-14 11:00AM  Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 On August 12, 2014 PR Newswire
Jul-24-14 07:38AM  Array BioPharma, Inc. (ARRY) Jumps: Stock Surges 10.7% Higher Zacks
Jul-23-14 02:24PM  Why Oncotheryeon, Inc., OncoMed Pharmaceuticals, Inc., and Array BioPharma Inc. Stocks Jumped Today at Motley Fool +10.69%
Jun-12-14 10:58AM  3 Reasons to Watch Array Biopharma Inc. at Motley Fool
Jun-11-14 02:00PM  Array BioPharma To Present At The Wells Fargo Securities 2014 Healthcare Conference PR Newswire
Jun-02-14 03:49PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
01:02PM  Array BioPharma receives orphan status for kinase inhibitor at theflyonthewall.com
01:00PM  Two Array-Invented MEK Inhibitors Showcased At ASCO PR Newswire
May-31-14 09:20AM  Eight Analyst Stocks to Buy Under $10 for Big Upside 24/7 Wall St.
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. The company's products in Phase III clinical trials include Binimetinib and Encorafenib for the treatment of cancer. Its clinical programs in Phase II clinical trial include ARRY-797, a p38 program for Lamin A/C-related dilated cardiomyopathy; and ARRY-502, a CRTh2 antagonist to treat Th2-driven allergic disease. The company's proprietary programs also comprise Filanesib, a kinesin spindle protein inhibitor for multiple myeloma; and ARRY-614, a p38/Tie2 dual inhibitor for myelodysplastic syndromes. Its partnered clinical programs include various drug candidates; Selumetinib, an MEK inhibitor for cancer; ASLAN001/ARRY-543, an HER2/EGFR inhibitor for gastric cancer; Ipatasertib/GDC-0068, an AKT inhibitor for cancer; VTX-2337, a toll-like receptor for cancer; and Danoprevir, a Hepatitis C virus protease inhibitor. The company's partnered clinical programs also comprise LY2606368, an Chk-1 inhibitor for cancer; GDC-0575, an Chk-1 inhibitor for cancer; ARRY-380/ONT-380, an HER2 inhibitor for breast cancer,; GDC-0994, an ERK inhibitor for cancer; and LOXO-101, an PanTrk inhibitor for cancer. It has collaborations with Celgene Corporation; Celgene Alpine Investment Co., LLC; Genentech, Inc.; Loxo Oncology, Inc; Novartis International Pharmaceutical Ltd.; and Oncothyreon Inc. The company was founded in 1998 and is headquartered in Boulder, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LEFKOFF KYLEDirectorMar 03Option Exercise2.8070,000196,05073,585Mar 04 08:50 PM
LEFKOFF KYLEDirectorMar 03Sale8.0070,000560,0703,585Mar 04 08:50 PM
Squarer RonCEOMar 02Sale8.2540,000330,00012,927Mar 04 08:13 PM
Robbins Andrews RSVP, Commercial OperationsMar 02Sale8.2521,576178,0020Mar 04 08:16 PM
Robbins Andrews RSVP, Commercial OperationsMar 01Option Exercise7.9632,069255,26932,069Mar 04 08:16 PM
Sandor VictorChief Medical Officer.Mar 01Option Exercise7.9617,440138,82217,440Mar 04 08:16 PM
MOORE JOHN RVP, General CounselMar 01Option Exercise7.9622,906182,33222,906Mar 04 08:14 PM
Squarer RonCEOMar 01Option Exercise7.9677,881619,93377,881Mar 04 08:13 PM
SNITMAN DAVIDCOO and VP, Business Devel.Mar 01Option Exercise7.9611,45391,16611,453Mar 04 08:12 PM
Saccomano Nicholas ACSOMar 01Option Exercise7.9611,45391,16611,453Mar 04 08:13 PM